Preferred Name

Fentanyl

Synonyms

Rapinyl

Fentanylum (INN-Latin)

Pentanyl

Duragesic

Fentanest

Durogesic

Duragesic-100

fentanyl

Sublimaze

Fentanil

Phentanyl

Actiq

Sentonil

Fentanila (INN-Spanish)

Nasalfent

Fentanyl citrate

Definitions

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) Pharmacology: Fentanyl is an opioid analgesic. Fentanyl interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, Fentanyl exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Fentanyl may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Fentanyl depresses the respiratory centers, depresses the cough reflex, and constricts the pupils. Mechanism of action: Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Fentanyl's analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. Drug type: Approved. Illicit. Investigational. Small Molecule. Drug category: Adjuvants. Adjuvants, Anesthesia. Analgesics. Analgesics, Opioid. Anesthetics. Anesthetics, Intravenous. Narcotics. Opiate Agonists

ID

http://uri.neuinfo.org/nif/nifstd/DB00813

createdDate

March 5, 2010

definition

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) Pharmacology: Fentanyl is an opioid analgesic. Fentanyl interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, Fentanyl exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Fentanyl may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Fentanyl depresses the respiratory centers, depresses the cough reflex, and constricts the pupils. Mechanism of action: Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Fentanyl's analgesic activity is, most likely, due to its conversion to morphine. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. Drug type: Approved. Illicit. Investigational. Small Molecule. Drug category: Adjuvants. Adjuvants, Anesthesia. Analgesics. Analgesics, Opioid. Anesthetics. Anesthetics, Intravenous. Narcotics. Opiate Agonists

has characteristic

http://uri.neuinfo.org/nif/nifstd/nlx_chem_090801

label

Fentanyl

prefixIRI

NIFSTD:DB00813

prefLabel

Fentanyl

synonym

Rapinyl

Fentanylum (INN-Latin)

Pentanyl

Duragesic

Fentanest

Durogesic

Duragesic-100

fentanyl

Sublimaze

Fentanil

Phentanyl

Actiq

Sentonil

Fentanila (INN-Spanish)

Nasalfent

Fentanyl citrate

subClassOf

http://uri.neuinfo.org/nif/nifstd/nlx_chem_1003011

http://purl.obolibrary.org/obo/CHEBI_23367

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_119915 CHEBI LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/373492002 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/ATC/N01AH01 ATC LOOM
http://purl.bioontology.org/ontology/ATC/N02AB03 ATC LOOM
http://stirdf.jst.go.jp/id/200907014848241629 IOBC LOOM
http://www.phoc.org.cn/pmo/class/PMO_00018284 PMAPP-PMO LOOM
https://go.drugbank.com/drugs/DB00813 MDM LOOM
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Fentanyl APAONTO LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C494 NCIT LOOM
http://purl.bioontology.org/ontology/LNC/MTHU066198 LOINC LOOM
http://purl.obolibrary.org/obo/MESH_D005283 BERO LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147049 NDFRT LOOM
http://www.limics.fr/ontologies/ontoparonmed#Durogescic ONTOPARON LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0015846 OCHV LOOM
http://purl.obolibrary.org/obo/OMIT_0006499 OMIT LOOM
http://purl.bioontology.org/ontology/NDDF/003571 NDDF LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D03.383.621.265 RH-MESH LOOM
http://purl.bioontology.org/ontology/RXNORM/4337 RXNORM LOOM
http://purl.bioontology.org/ontology/CPT/80354 CPT LOOM
http://purl.jp/bio/4/id/200906046252972079 IOBC LOOM
http://purl.bioontology.org/ontology/LNC/MTHU060433 LOINC LOOM
http://purl.bioontology.org/ontology/CSP/2332-6903 CRISP LOOM
http://purl.bioontology.org/ontology/VANDF/4018745 VANDF LOOM
http://purl.obolibrary.org/obo/SCDO_0001321 SCDO LOOM
http://www.limics.fr/ontologies/ontoparonmed#Durogesic ONTOPARON LOOM
http://www.co-ode.org/ontologies/galen#Fentanyl GALEN LOOM
http://purl.bioontology.org/ontology/LNC/LA28602-3 LOINC LOOM
http://www.drugbank.ca/drugs/DB00813 FTC LOOM
http://purl.bioontology.org/ontology/LNC/LP15167-7 LOINC LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 OBIB LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_119915 ODNAE LOOM
http://purl.bioontology.org/ontology/SNMI/C-60650 SNMI LOOM
http://purl.obolibrary.org/obo/NCIT_C494 BERO LOOM
http://purl.bioontology.org/ontology/MESH/D005283 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D005283 RH-MESH LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#4970 OCHV LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000147049 ODAE LOOM